Anti-Siglec-8 antibodies and methods of use thereof
US9546215B2 · kind B2 · utility
5Cited by
53References
68Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2014 |
| Grant date | Jan 17, 2017 |
| Priority date | — |
| Expiry date | Feb 24, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides humanized anti-Siglec-8 antibodies and their use in treating and preventing eosinophil-mediated disorders and/or mast cell-mediated disorders, as well as compositions and kits comprising the humanized anti-Siglec-8 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.